End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
280.5 TWD | -0.71% | -2.09% | +3.12% |
Business Summary
Number of employees: 1,099
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
99.4
%
| 14,503 | 99.1 % | 16,864 | 99.4 % | +16.28% |
Other
0.6
%
| 130 | 0.9 % | 94 | 0.6 % | -27.72% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
40.2
%
| 5,916 | 40.4 % | 6,815 | 40.2 % | +15.18% |
South Korea
32.9
%
| 5,277 | 36.1 % | 5,587 | 32.9 % | +5.86% |
Taiwan
14.2
%
| 1,439 | 9.8 % | 2,413 | 14.2 % | +67.67% |
Others
12.6
%
| 2,000 | 13.7 % | 2,144 | 12.6 % | +7.18% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 29/14/29 | |
I ling Tian
DFI | Director of Finance/CFO | - | 01/16/01 |
Ying Ming Yue
COO | Chief Operating Officer | - | 01/22/01 |
Gwen Hsieh
CIO | Chief Investment Officer | - | 02/21/02 |
Manisha Chawla
CTO | Chief Tech/Sci/R&D Officer | - | 08/19/08 |
Edin Buljubašic
CMP | Compliance Officer | - | 01/22/01 |
Erica Yen
IRC | Investor Relations Contact | - | - |
Bjartur Shen
IRO | Public Communications Contact | - | 16/18/16 |
Ryan Koh
AUD | Comptroller/Controller/Auditor | - | 10/22/10 |
Prashant Godse
PRN | Corporate Officer/Principal | - | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 11/14/11 | |
Director/Board Member | 61 | 23/15/23 | |
Árni Harðarson
BRD | Director/Board Member | 57 | 11/14/11 |
Chief Executive Officer | - | 29/14/29 | |
Mu Yao Ku
BRD | Director/Board Member | - | 29/14/29 |
Director/Board Member | 59 | - | |
Yves Hermes
BRD | Director/Board Member | - | 30/22/30 |
Director/Board Member | - | 30/22/30 | |
Director/Board Member | - | 30/22/30 | |
Director/Board Member | - | 23/22/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 264,958,300 | 128,414,312 ( 48.47 %) | 490,000 ( 0.1849 %) | 48.47 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
FUJI PHARMA CO., LTD. 4.92% | 1,219,000 | 4.92% | 12,316,654 $ |
Company contact information
Lotus Pharmaceutical Co., Ltd.
No. 277, Song Ren Road 17/F, Xin Yi District
110 58, Taipei
+
http://www.lotuspharm.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.12% | 230.4Cr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 32TCr | |
+0.24% | 27TCr | |
+13.47% | 24TCr | |
+7.35% | 20TCr | |
-6.42% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |
- Stock Market
- Equities
- 1795 Stock
- Company Lotus Pharmaceutical Co., Ltd.